Table 4.

Combined NAT1 and NAT2 diplotypes and risk of pancreatic cancer

NAT1 diplotypeNAT2 diplotypePatients (n = 524), n (%)Controls (n = 578), n (%)OR* (95% CI)
All otherAll other512 (97.7)575 (99.5)1.00
*10/*10 + *10/*11*6A/*5 + *6A/*6 + *6A/*712 (2.3)3 (0.5)4.15 (1.15-15.00)
  • * OR (95% CI) adjusted for age, sex, pack-year of smoking (categorized as never smokers, light smokers, and heavy smokers), and diabetes (no versus yes).